ACS CoC Special Study 2017
congress program
Improving the current approach to surveillance after active treatment
for cancer has been identified as a priority area by a number of
organizations, including the Institute of Medicine, Patient-Centered
Outcomes Research Institute, and DEcIDE Cancer Consortium. The current
guidelines do not account for individual risk and are based on limited
evidence. To help address this gap, a Special Study will be launched in
the coming months to investigate follow-up and recurrence after prostate
cancer treatment in hopes of tailoring follow-up based on individual
risk. This study will involve analyzing data from the National Cancer
Data Base (NCDB) to determine surveillance patterns for prostate cancer.
It will be funded by a grant from the Patient Center Outcomes Research
Institute (PCORI).
The goal of this work is to better understand how patients are
currently being followed with surveillance testing and whether or not
this is influencing outcomes. In addition, these studies will look at
the accuracy of recurrence data within the NCDB and begin to develop
strategies and create opportunities to improve the collection of this
important outcome measure. Many tumor registrars are directly engaged to
help achieve these goals and we are looking forward to your
participation.
All videos of the conference ( 15 videos )
Suggest a video
